BMI1 and prostate cancer: They also illustrated the negative role of BMI1 O-GlcNAcylation in prostate cancer tumorigenesis, as it inhibits p53, PTEN, and CDKN1A/CDKN2A signaling, thus favorizing apoptosis, invasion and proliferation, respectively (Fig. 5a) [73].